INNV-14. ADJUVANT CHEMOTHERAPY AFTER SEVERE MYELOTOXICITY DURING TEMOZOLOMIDE CHEMORADIATION IN GLIOMAS. IT IS FEASIBILE?

INTRODUCTION: Malignant gliomas are aggressive primitive brain tumor in adults. Today, the standard of care is Temozolomide (TMZ) administered daily with radiation therapy, followed by adjuvant TMZ. TMZ treatment has been considered to have a low toxicity profile. However, during concomitant treatme...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neuro Oncol
Asıl Yazarlar: Villani, Veronica, Fabi, Alessandra, Gaviani, Paola, Rudà, Roberta, Lombardi, Giuseppe, Simonetti, Giorgia, Silvani, Antonio, Pronello, Edoardo, Minniti, Giuseppe, Pace, Andrea
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2019
Konular:
Innovations in Patient Care
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847069/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.557
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller